First Manhattan Co. continued to hold its stake in Aetna Inc. (NYSE:AET) during the second quarter, according to its most recent filing with the SEC. The fund owned 4,150 shares of the company’s stock at the end of the second quarter. First Manhattan Co.’s holdings in Aetna were worth $630,000 as of its most recent filing with the SEC.
Several other large investors have also recently added to or reduced their stakes in the company. FTB Advisors Inc. raised its stake in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares in the last quarter. Signature Estate & Investment Advisors LLC acquired a new position in Aetna during the first quarter worth approximately $133,000. Liberty Capital Management Inc. raised its position in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after buying an additional 629 shares in the last quarter. Horan Capital Management acquired a new position in Aetna during the first quarter worth approximately $157,000. Finally, Guardian Life Insurance Co. of America raised its position in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares in the last quarter. 91.69% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna Inc. (AET) traded down 0.87% during mid-day trading on Friday, hitting $154.45. 1,781,161 shares of the company’s stock traded hands. The stock has a 50 day moving average price of $154.81 and a 200-day moving average price of $140.38. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $161.69. The stock has a market cap of $51.29 billion, a P/E ratio of 34.28 and a beta of 0.54.
Aetna (NYSE:AET) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s revenue was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.21 EPS. Equities research analysts anticipate that Aetna Inc. will post $9.55 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “First Manhattan Co. Holds Position in Aetna Inc. (AET)” was originally reported by BNB Daily and is the sole property of of BNB Daily. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://www.baseball-news-blog.com/2017/08/19/first-manhattan-co-continues-to-hold-position-in-aetna-inc-aet-updated.html.
AET has been the topic of a number of recent research reports. Stifel Nicolaus restated a “buy” rating and issued a $150.00 price objective (up from $130.00) on shares of Aetna in a research note on Wednesday, May 3rd. Royal Bank Of Canada boosted their price target on shares of Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a research note on Friday, June 9th. BidaskClub lowered shares of Aetna from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Deutsche Bank AG boosted their price target on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Finally, UBS AG reiterated a “buy” rating and set a $160.00 price target (up from $147.00) on shares of Aetna in a research note on Wednesday, May 17th. Seven research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Aetna presently has an average rating of “Buy” and an average price target of $157.99.
In other news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total value of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.